Focus for BIO 2008
- Nexagon™ – a lead compound that represents a new paradigm in wound care – improves wound healing while significantly reducing inflammation and scarring
- Initial target markets are patients with eye damage caused by surgery or mechanical injury, anti-scarring, and acute surgical and chronic wounds
- Other potential indications include burns and central nervous system injuries
